Reduced ATP release from erythrocytes of humans with type 2 diabetes is increased by the phosphodiesterase 3 inhibitor cilostazol
Year: 2006
Type: article
Source: The FASEB Journal
Institution: Saint Louis University
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3176437920
